Raymond James Financial
XTNT icon

Raymond James Financial’s Xtant Medical Holdings XTNT Stock Holding History

Raymond James Financial’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-58
Closed -$43 – 6828
2025
Q2 		$43 Buy
+58
New +$33 ﹤0.01% 6895

Other funds holding XTNT

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Raymond James Financial's XTNT Position: Q3 2025 in Review

Raymond James Financial sold out of Xtant Medical Holdings (XTNT) in Q3 2025, closing a stake of 58 shares — an estimated $43 sold.

Raymond James Financial first reported a position in XTNT in Q2 2025 and held it in 1 quarter. The position peaked at $43 in Q2 2025. 30 funds tracked by Wall St. Rank hold XTNT as of Q3 2025.

  • Raymond James Financial reported no remaining Xtant Medical Holdings position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 58 Xtant Medical Holdings shares in Q3 2025, an estimated $43.
  • Raymond James Financial first reported a position in Xtant Medical Holdings in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Xtant Medical Holdings position peaked at $43 in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.